Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?

논문상세정보
' Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • AKI phenotypes
  • Acute kidney injury
  • Cell cycle arrest biomarker
  • Kidney biomarker
  • Kidney risk prediction
  • Preclinical AKI
  • Subclinical AKI
  • neutrophil gelatinase associated lipocalin
  • serumcreatinine
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
123 0

0.0%

' Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?' 의 참고문헌

  • What can we expect from biomarkers for acute kidney injury?
    Kellum JA [2014]
  • Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication
    Bihorac A [2014]
  • Use of cell cycle arrest biomarkers in conjunction with classical markers of acute kidney injury
    Joannidis M [2019]
  • Urinary, plasma, and serum biomarkers’ utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis
    Ho J [2015]
  • Urinary neutrophil gelatinase-associated lipocalin-guided risk assessment for major adverse kidney events after open-heart surgery
    Albert C [2018]
  • Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients
  • Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes
    Singer E [2011]
  • Urinary neutrophil gelatinase-associated lipocalin (NGAL) distinguishes sustained from transient acute kidney injury after general surgery
    Au V [2016]
  • Urinary hepcidin-25 is elevated in patients that avoid acute kidney injury following cardiac surgery
    Choi N [2018]
  • Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass
    Ho J [2011]
  • Urinary biomarkers of AKI and mortality 3 years after cardiac surgery
    Coca SG [2014]
  • Urinary biomarkers may provide prognostic information for subclinical acute kidney injury after cardiac surgery
    Albert C [2018]
  • Urinary NGAL-positive acute kidney injury and poor long-term outcomes in hospitalized patients
    Singer E [2016]
  • Urinary Biomarkers may Complement the Cleveland Score for Prediction of Adverse Kidney Events After Cardiac Surgery: A Pilot Study
  • Treatment, clinical course, and cross-sectoral information transmission in patients with acute-on-chronic kidney injury
  • Tissue inhibitor metalloproteinase-2 (TIMP-2)•IGF-binding protein-7(IGFBP-7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury
    Xie Y [2019]
  • Tissue Inhibitor Metalloproteinase-2 (TIMP-2)•IGF-Binding Protein-7(IGFBP-7) levels are associated with adverse long-term outcomes in patients with AKI
    Koyner JL [2015]
  • The role of hepcidin in iron metabolism
    Nemeth E [2009]
  • The predictive performance of plasma neutrophil gelatinase-associated lipocalin (NGAL) increases with grade of acute kidney injury
  • The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies
    Haase M [2011]
  • The identification of three novel biomarkers of major adverse kidney events
    Haase M [2014]
  • The effects of intensive versus routine treatment in patients with acute kidney injury
  • The clinical utility window for acute kidney injury biomarkers in the critically ill
    Ralib AM [2014]
  • The clinical utility of plasma neutrophil gelatinase-associated lipocalin in acute kidney injury
  • The cardiac surgery-associated neutrophil gelatinase-associated lipocalin (CSA-NGAL) score: a potential tool to monitor acute tubular damage
    de Geus HRH [2016]
  • Subclinical AKI–an emerging syndrome with important consequences
    Haase M [2012]
  • Subclinical AKI: ready for primetime in clinical practice?
  • Short-term prognostic implications of serum and urine neutrophil gelatinase-associated lipocalin in acute heart failure: findings from the AKINESIS study
  • Serum cystatin C for the diagnosis of acute kidney injury in patients admitted in the emergency department
  • Serum creatinine level, a surrogate of muscle mass, predicts mortality in critically ill patients
  • Routine adoption of TIMP2 and IGFBP-7 biomarkers in cardiac surgery for early identification of acute kidney injury
    Levante C [2017]
  • Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
    Damman K [2014]
  • Renal handling of circulating and renal-synthesized hepcidin and its protective effects against hemoglobin-mediated kidney injury
  • Renal functional reserve and renal recovery after acute kidney injury
    Sharma A [2014]
  • Reduced production of creatinine limits its use as marker of kidney injury in sepsis
    Doi K [2009]
  • Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure
    Maisel AS [2002]
  • Quality improvement goals for acute kidney injury
    Kashani K [2019]
  • Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis
  • Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT network study
    Ng LL [2017]
  • Proenkephalin, Neutrophil Gelatinase-Associated Lipocalin, and Estimated Glomerular Filtration Rates in Patients With Sepsis
    김한아 [2017]
  • Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues
    Denning GM [2008]
  • Proenkephalin a 119–159 (penKid)–a novel biomarker for acute kidney injury in sepsis: an observational study
  • Proenkephalin Predicts Organ Failure, Renal Replacement Therapy, and Mortality in Patients With Sepsis
    Hanah Kim [2020]
  • Proenkephalin A 119-159 (Penkid) is an early biomarker of septic acute kidney injury: the Kidney in Sepsis and Septic Shock (KidSSS) study
    Hollinger A [2018]
  • Proenkephalin (PENK) as a novel biomarker for kidney function
    Beunders R [2017]
  • Pro-enkephalin in plasma of surgical icu-patients with sepsis - a pilot study
    Doemming S [2015]
  • Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial
    Meersch M [2017]
  • Preoperative renal risk stratification
    Chertow GM [1997]
  • Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery
  • Predictive value of NGAL for use of renal replacement therapy in patients with severe sepsis
    Hjortrup PB [2015]
  • Pre-renal azotemia:a flawed paradigm in critically ill septic patients?
    Bellomo R [2007]
  • Post–acute kidney injury proteinuria and subsequent kidney disease progression: the Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) study
    Hsu CY [2020]
  • Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery
    Parikh CR [2011]
  • Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery
    Parikh CR [2011]
  • Plasma Neutrophil Gelatinase-Associated Lipocalin as a Marker of Tubular Damage in Diabetic Nephropathy
    김소영 [2018]
  • Plasma NGAL similarly predicts acute kidney injury in sepsis and nonsepsis
    de Geus HRH [2013]
  • Phenotyping of acute kidney injury: beyond serum creatinine
    Moledina DG [2018]
  • Perioperative hemodynamic instability and fluid overload are associated with increasing acute kidney injury severity and worse outcome after cardiac surgery
  • Performance of cystatin C– and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics
    Meeusen JW [2015]
  • Pathophysiology of AKI
    Ostermann M [2017]
  • Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury
    Haase M [2010]
  • Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults
    Haase M [2009]
  • New metrics for assessing diagnostic potential of candidate biomarkers
  • Neutrophil gelatinase-associated lipocalin(NGAL)as a biomarker for acute renal injury after cardiac surgery
    Mishra J [2005]
  • Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study
    Maisel AS [2016]
  • Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status
  • Neutrophil Gelatinase-Associated Lipocalin Measured on Clinical Laboratory Platforms for the Prediction of Acute Kidney Injury and the Associated Need for Dialysis Therapy: A Systematic Review and Meta-analysis
  • NGAL usefulness in the Intensive Care Unit three hours after cardiac surgery
    Delcroix G [2012]
  • NGAL for the detection of acute kidney injury in the emergency room
    Devarajan P [2014]
  • Molecular phenotyping of clinical AKI with novel urinary biomarkers
    Huen SC [2015]
  • Methods used to assess the performance of biomarkers for the diagnosis of acute kidney injury: a systematic review and meta-analysis
    Codorniu A [2018]
  • Linking injury to outcome in acute kidney injury: a matter of sensitivity
  • Lack of significant renal tubular injury despite acute kidney injury in acute decompensated heart failure
    Dupont M [2012]
  • Kidney disease: improving global outcomes (KDIGO)Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney
    Kellum JA [2012]
  • Iron, hepcidin, and death in human AKI
    Leaf DE [2019]
  • Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells
    Emlet DR [2017]
  • Incidence, outcomes, and comparisons across definitions of AKI in hospitalized individuals
    Zeng X [2014]
  • Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function
    Endre ZH [2011]
  • Imperfect gold standards for kidney injury biomarker evaluation
    Waikar SS [2012]
  • Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
    Hoste E [2020]
  • High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database
    Heywood JT [2007]
  • Greater increase in urinary hepcidin predicts protection from acute kidney injury after cardiopulmonary bypass
    Prowle JR [2012]
  • Food and Drug Administration Letter to Astute Medical 2014
  • Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
    Pencina MJ [2008]
  • Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD
    Stevens LA [2008]
  • Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury
    Mori K [2005]
  • Elevated soluble urokinase plasminogen activator receptor and proenkephalin serum levels predict the development of acute kidney injury after cardiac surgery
    Mossanen JC [2017]
  • Electronic alerts for acute kidney injury
    Haase M [2017]
  • Early warning systems in acute kidney insufficiency
  • Early serum cystatin C-enhanced risk prediction for acute kidney injury post cardiac surgery: a prospective, observational, cohort study
    Wang X [2020]
  • Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
    Parikh A [2017]
  • Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
    Kashani K [2013]
  • Direct comparison of 4 very early rule-out strategies for acute myocardial infarction using high-sensitivity cardiac troponin I
  • Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis
    Zhou F [2016]
  • Diagnostic prediction of urinary [TIMP-2]×[IGFBP-7] for acute kidney injury: a meta-analysis exploring detection time and cutoff levels
    Song Z [2017]
  • Diagnostic and short-term prognostic utility of plasma pro-enkeph-alin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department
    Marino R [2015]
  • Diagnostic and prognostic stratification in the Emergency Department using urinary biomarkers of nephron damage: a multicenter prospective cohort study
    Nickolas TL [2012]
  • Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference
  • Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers
    Hoste EAJ [2014]
  • Cystatin C-based CKDEPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure
  • Cystatin C for risk stratification in patients after an acute coronary syndrome
    Correa S [2018]
  • Cystatin C as a biomarker for estimating glomerular filtration rate
    Ferguson TW [2015]
  • Creatinine kinetics and the definition of acute kidney injury
    Waikar SS [2009]
  • Comparing Results of Five Glomerular Filtration Rate-Estimating Equations in the Korean General Population: MDRD Study, Revised Lund-Malmӧ, and Three CKD-EPI Equations
    Misuk Ji [2016]
  • Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass
    Liangos O [2009]
  • Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury
    Heung M [2016]
  • Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgery
    Basu RK [2014]
  • Clinical use of the urine biomarker [TIMP-2]×[IGFBP-7] for acute kidney injury risk assessment
    Vijayan A [2016]
  • Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock
    Caironi P [2018]
  • Chronic kidney disease staging with cystatin C or creatinine-based formulas: flipping the coin
    Luis-Lima S [2019]
  • Cardiac and vascular surgery–associated acute kidney injury: the 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group
    Nadim MK [2018]
  • Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption
    Kashani K [2017]
  • Biomarkers in acute kidney injury: are we ready for prime time?
    Devarajan P [2014]
  • Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis
    Klein SJ [2018]
  • Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study
    Göcze I [2018]
  • B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD)and aggregate data
    Pufulete M [2018]
  • Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury
    Bell M [2015]
  • Additive value of blood neutrophil gelatinase- associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department
    Di Somma S [2013]
  • Acute renal failure following cardiac surgery
    Conlon PJ [1999]
  • Acute renal failure during sepsis: potential role of cell cycle regulation
    Yang QH [2009]
  • Acute kidney stress–a useful term based on evolution in the understanding of acute kidney injury
    Katz N [2016]
  • Acute kidney injury, mortality, length of stay, and costs in hospitalized patients
    Chertow GM [2005]
  • Acute kidney injury risk assessment and the Nephrology Rapid Response Team
  • Acute kidney injury
    Ronco C [2019]
  • Acute Dialysis Quality Initiative workgroup. Acute renal failure–definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Bellomo R [2004]
  • Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis
    Haase M [2009]
  • AKI biomarkers are poor discriminants for subsequent need for renal replacement therapy, but do not disqualify them yet
  • 0/1-hour triage algorithm for myocardial infarction in patients with renal dysfunction